RESUMO
BACKGROUND: Splenectomized patients are at higher risk of severe infection. PATIENTS AND METHOD: This retrospective study was performed to evaluate compliance with guidelines in patients who underwent a splenectomy between 1978 and 2000. Seventy-five patients were identified and their hospital records were reviewed. RESULTS: 62.7% of patients who had a splenectomy received a pneumococcal vaccine and were aware of the infectious risks related to an asplenic status. CONCLUSIONS: Rapidly lethal overwhelming sepsis in some asplenic patients demands greater prevention efforts by physicians.
Assuntos
Infecções Bacterianas/prevenção & controle , Esplenectomia/efeitos adversos , Adolescente , Adulto , Idoso , Infecções Bacterianas/etiologia , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , EspanhaRESUMO
Systemic mast cell disease (SMCD) is an idiopathic disorder in which mast cells proliferate and accumulate in various organs including the skin, bone marrow, liver, spleen and lymph nodes. SMCD is regarded as a myeloproliferative disorder for any authors. Associated hematologic disorders can be found in up to one third of patients with SMCD. It may be due to the apparent close relationship between the mast cell and the myeloid cell.
Assuntos
Leucemia Mieloide/etiologia , Mastocitose/complicações , Doença Aguda , Biópsia por Agulha , Medula Óssea/patologia , Evolução Fatal , Humanos , Leucemia Mieloide/patologia , Masculino , Mastocitose/patologia , Pessoa de Meia-Idade , Fatores de TempoRESUMO
La mastocitosis sistémica es una enfermedad en la cual los mastocitos proliferan y se acumulan en distintos tejidos como la piel, médula ósea, hígado, bazo y ganglios linfáticos. Algunos autores la consideran como un síndrome mieloproliferativo. Una tercera parte de los pacientes desarrollan otras neoplasias hematológicas, apoyando el origen mieloide del mastocito (AU)
